Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-013094

Director acquired 1,093 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2023-09-05 Other acquisition 10b5-1 +65 $1.68 $109 28,105 D
Jones James Director 2023-09-06 Other acquisition 10b5-1 +65 $1.65 $107 28,170 D
Jones James Director 2023-09-07 Other acquisition 10b5-1 +65 $1.68 $109 28,235 D
Jones James Director 2023-09-08 Other acquisition 10b5-1 +65 $1.68 $109 28,300 D
Jones James Director 2023-09-11 Other acquisition 10b5-1 +65 $1.72 $112 28,365 D
Jones James Director 2023-09-12 Other acquisition 10b5-1 +65 $1.76 $114 28,430 D
Jones James Director 2023-09-13 Other acquisition 10b5-1 +65 $1.83 $119 28,495 D
Jones James Director 2023-09-14 Other acquisition 10b5-1 +65 $1.84 $120 28,560 D
Jones James Director 2023-09-15 Other acquisition 10b5-1 +23 $1.82 $42 28,583 D
Jones James Director 2023-09-18 Other acquisition 10b5-1 +55 $2.03 $112 28,638 D
Jones James Director 2023-09-19 Other acquisition 10b5-1 +55 $2.12 $117 28,693 D
Jones James Director 2023-09-20 Other acquisition 10b5-1 +55 $2.14 $118 28,748 D
Jones James Director 2023-09-21 Other acquisition 10b5-1 +55 $2.28 $125 28,803 D
Jones James Director 2023-09-22 Other acquisition 10b5-1 +55 $2.29 $126 28,858 D
Jones James Director 2023-09-25 Other acquisition 10b5-1 +55 $2.24 $123 28,913 D
Jones James Director 2023-09-26 Other acquisition 10b5-1 +55 $2.07 $114 28,968 D
Jones James Director 2023-09-27 Other acquisition 10b5-1 +55 $1.98 $109 29,023 D
Jones James Director 2023-09-28 Other acquisition 10b5-1 +55 $1.96 $108 29,078 D
Jones James Director 2023-09-29 Other acquisition 10b5-1 +55 $1.90 $105 29,133 D
Loading xslF345X05/marketforms-62745.xml…